For the last couple of years, the rapid at-home COVID tests that can identify an infection with a simple swab of the nose have been a mainstay of efforts to diagnose infection with the SARS-CoV-2 virus and prevent its spread.
Jun 15, 2023
0
12
Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID.
Sep 11, 2023
0
32
In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients differ in their ...
Sep 18, 2014
0
0
Scientists have identified a 'molecular barcode' in the blood of patients with Ebola virus disease that can predict whether they are likely to survive or die from the viral infection.
Jan 19, 2017
0
0
A systematic review of evidence being presented at this week's ESCMID Conference on Coronavirus Disease shows that air around patients with COVID-19, as well as patients toilets, and staff and public areas in hospitals are ...
Sep 23, 2020
0
3
Most HIV-positive people in France under treatment take a daily dose of antiviral drugs for life. However, a major trial is currently underway that may confirm that patients could omit several days of treatment a week without ...
Dec 1, 2017
0
0
Community pharmacists in the United States have a unique opportunity to consult with customers about HIV treatment when selling over-the-counter HIV tests, according to a study by researchers at the Indiana University School ...
Jul 16, 2013
0
0
The COVID-19 pandemic tends to conceal other important health issues. One of these is the global target for reducing HIV infections and increasing access to treatment. Progress is well under way. In 2019, 67% of those living ...
Sep 4, 2020
0
4
Laboratory tests have revealed resistance in some H7N9 bird flu patients to the only available treatment, said virologists who unveiled "concerning" study results on Tuesday.
May 28, 2013
0
0
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.
Apr 23, 2024
0
25
